Gives contract “there is not no obligation towards’EU“, But only the commitment to do“ our best ”. And at this moment not even a part of the supplies of Covid vaccines intended for UK it can be diverted to the countries of the Union, because “the agreement with governo Johnson It has been reached three months before“. This version was also confirmed by sources from Downing Street al Telegraph. After controversy for the announcement of a cut at the first deliveries scheduled for February, speak Pascal Soriot, CEO of the pharmaceutical company AstraZeneca. His version, however, is contested by Brussels, which at this point – they explain to theAnsa EU sources – asks release from the clause of secrecy to publish the contract. In particular, the sources clarify that it is not envisaged that the production of doses for the EU should be limited to factory in Belgium, but it can happen also in the UK. And it is now open confrontation between Brussels and AstraZeneca on the company’s participation in the meeting of executive committee on EU vaccines, scheduled for 18.30. The EU had announced the company’s participation, but sources inside AstraZeneca had denied the presence. This provoked the reaction of the EU that a few minutes later “insisted that AstraZeneca attend the meeting to provide all the requested explanations”, but the spokesperson for the Commission Dana Spinant he then clarified that “AstraZeneca has informed us this morning that its participation is not confirmed and that it will not be there”, adding that the situation is evolving and therefore cannot provide a definitive answer on the meeting. But in turn the company has denied the Commission’s words, according to a note cited by Telegraph: “We will meet with the EU within the day,” said a spokesman. In the meantime, thebomb alarm at the company’s plant in Wales for the presence of a suspicious package: employees evacuated.
Soriot, interviewed by Republic, rejects the suspicions advanced in recent days by European Commission, that fears some doses destined for EU countries have ended up elsewhere and for this reason he wants to establish a transfer register vaccines outside the Union. “We certainly do not divert Europeans’ vaccines to other countries. Would be illogical and counterproductive on our part “, claims the 61-year-old Frenchman, who defends himself for the delays:” The problems in the EU have been A case and they are certainly not intentional ”. AstraZeneca, promises its CEO, aims to “deliver to the EU 17 million doses by the end of February. Of these, 2,5 about in Italy “. First, however, it is missing authorization by the EMA.